← Open Payments lookup

CONFIDENCE ALABOSON: Open Payments

NPI 1750954970 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,686 in 130 payments from 47 companies in 2025. Trend: 2023 $3,375 · 2024 $3,164 · 2025 $3,686

Food & beverage: $3,138Education: $548
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$387
Incyte Corporation5$257
Novartis Pharmaceuticals Corporation8$222
Eisai Inc.7$191
Merck Sharp & Dohme LLC7$189
GlaxoSmithKline, LLC.7$161
Daiichi Sankyo Inc.7$154
Alexion Pharmaceuticals, Inc.3$152
E.R. Squibb & Sons, L.L.C.5$123
Janssen Biotech, Inc.4$110

Products named: Lenvima, KEYTRUDA, Enhertu, OJJAARA, Fabhalta, VERZENIO, CALQUENCE, SOLIRIS.

Industry payments across TX — which companies pay providers there.